Posted inCardiology Nephrology news
Finerenone Efficacy in Cardio-Kidney-Metabolic Syndrome Patients With or Without History of Cancer: Insights from the FINE-HEART Analysis
Finerenone reduces mortality, cardiovascular, and kidney complications in cardio-kidney-metabolic syndrome patients regardless of cancer history, while patients with cancer experience greater disease burden and adverse events.
